Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies-Reference-Cited by-同舟云学术

Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies

Published:2012-08-22 Issue:7 Volume:28 Page:738-744
ISSN:0885-6230
Container-title:International Journal of Geriatric Psychiatry
language:en
Short-container-title:Int J Geriatr Psychiatry

Author:

Brunnström Hans¹,Hansson Oskar²,Zetterberg Henrik³,Londos Elisabet²,Englund Elisabet¹

Affiliation:

1. Department of Pathology; Lund University and Regional Laboratories Region Skåne; Lund; Sweden

2. Clinical Memory Research Unit, Institute of Clinical Sciences in Malmö; Lund University; Sweden

3. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology; The Sahlgrenska Academy at the University of Gothenburg; Mölndal; Sweden

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Reference34 articles.

1. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease;Andreasen;Arch Neurol,1999

2. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?;Blennow;Mol Chem Neuropathol,1995

3. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease;Blennow;Nat Rev Neurol,2010

4. Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies;Boström;Dement Geriatr Cogn Disord,2009

5. Neuropathological staging of Alzheimer-related changes;Braak;Acta Neuropathol,1991

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases;Journal of the Neurological Sciences;2024-07

2. Synucleinopathies and their laboratory biomarkers;Česká a slovenská neurologie a neurochirurgie;2021-12-31

3. Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer’s Disease and Cognitively Healthy People;Journal of Alzheimer's Disease;2021-06-01

4. Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease;Acta Neuropathologica Communications;2020-11-19

5. Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis;Parkinsonism & Related Disorders;2020-11